Saxagliptin Triple Oral Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

257

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Type 2 Diabetes
Interventions
DRUG

Saxagliptin

5 mg tablet once daily for 24 weeks to be taken orally

DRUG

Placebo

tablet once daily for 24 weeks to be taken orally

Trial Locations (33)

Unknown

Research Site, Broadmeadow

Research Site, Wollongong

Research Site, Daw Park

Research Site, Elizabeth Vale

Research Site, Melbourne

Research Site, Camperdown

Research Site, Herston

Research Site, St. John's

Research Site, Sydney Mines

Research Site, Thornhill

Research Site, Kensington

Research Site, Karnāl

Research Site, Bangalore

Research Site, Indore

Research Site, Pune

Research Site, Coimbatore

Research Site, Wŏnju

Research Site, Goyang

Research Site, Daegu

Research Site, Seoul

Research Site, Bangkok

Research Site, Reading

Research Site, Ely

Research Site, Whitstable

Research Site, Westbury

Research Site, Ashford

Research Site, Belfast

Research Site, Blackpool

Research Site, Chesterfield

Research Site, Coventry

Research Site, Glasgow

Research Site, Peterborough

Research Site, Wellingborough

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY